CPR Invest - European Strategic Autonomy - I EUR - Acc ISIN : LU2570611249

CPR Invest - European Strategic Autonomy - I EUR - Acc
I EUR(C) - LU2570611249
Asset class: Equities

YTD
As of 18/11/2026
5.95%

Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.

NAV
As of 18/11/2026
€144.17

SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8

Fund AUM
As of 18/11/2026
€1.08B
The investment objective is to outperform European equity markets over a long-term period (minimum of five years) by investing in equities involved in strategic sectors that contribute to Europe’s autonomy and resilience, while integrating Environmental, Social and Governance (ESG) criteria in the investment process.
 

NAVs

NAV from 28/03/2023 to 18/11/2026
Select period
Created with Highcharts 11.4.8CPR Invest - European Strategic Autonomy - I EUR - AccApr '23Jul '23Oct '23Jan '24Apr '24Jul '24Oct '24Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '2680100120140160180

Performance

Change in NAV in base 100
FundCPR Invest - European Strategic Autonomy - I EUR - Acc (47.99% over the period)
Select period
Created with Highcharts 11.4.8CPR Invest - European Strategic Autonomy - I EUR - AccBenchmarkApr '23Jul '23Oct '23Jan '24Apr '24Jul '24Oct '24Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '2680100120140160180
FundCPR Invest - European Strategic Autonomy - I EUR - Acc (47.99% over the period)
Select period
Created with Highcharts 11.4.8CPR Invest - European Strategic Autonomy - I EUR - AccBenchmarkApr '23Jul '23Oct '23Jan '24Apr '24Jul '24Oct '24Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '2680100120140160180

Portfolio Analysis

Repartition 10/31/2026
Sector
Weight
Spread / Index
ASML HOLDING NVInformation Technology7.91%-1.04%
SIEMENS AG-REGIndustrials3.29%0.25%
BANCO SANTANDER SA MADRIDFinancials3.25%0.95%
AIRBUS SE PARISIndustrials2.91%1.12%
SAP SE / XETRAInformation Technology2.83%-0.42%
ALLIANZ SE-REGFinancials2.67%0.11%
COMPAGNIE DE SAINT GOBAINIndustrials2.67%2.21%
SAFRAN SAIndustrials2.50%1.03%
COMMERZBANK AGFinancials2.45%2.10%
SCHNEIDER ELECT SEIndustrials2.43%0.34%

Management commentary

Effective date: 31/10/2026
In October, the fund recorded a performance of -3.13%, compared to -1.58% for the MSCI EMU Net Total Return index. Year-to-date, the fund is up 6.41%, versus 9.06% for its benchmark index.
 
The start of the season was particularly eventful, both from a geopolitical perspective with the ongoing stalemate between the United States and Iran. President Trump publicly hinted that the time for a decision was approaching, wavering between concluding an agreement or resuming military operations against Tehran. The price of a barrel continued its upward trajectory begun in June, with a monthly increase of 13.6%. Brent futures are now trading at $100 levels until next May. Inflation therefore remains high; in Europe, it was 3.8%, driven by energy prices. In this context, purchasing power is deteriorating and protests have multiplied across Europe, particularly in France. Added to this were concerns related to AI financing. The catalyst was the surge in Coreweave’s CDS. The risk of a credit bubble forming in Neoclouds had a contagion effect across the entire technology sector. The dependence on capex and the credit market to finance them is worrying.
 
In this context, stocks related to electrification were heavily penalized both within technology (ASML, ASMI, and Infineon down by 11.41%, 17.82%, and 15.03% respectively) and within industrials (Siemens Energy, Legrand, Prysmian down by 11%, 10.97%, and 7.49%). The defense sector rebounded slightly, but engine manufacturers suffered particularly from tensions in oil prices; thus, Safran and Roll-Royce fell by 17.55% and 12.99%. The healthcare sector, as in the previous month, was a detractor, with significant declines from Abivax and Ottobock, down by -9.97% and -9.32% respectively.
Ingredients performed well over the month following strong earnings releases; DSM and Novonesis rose by 9.4% and 10.16%.
 
Regarding portfolio movements, we slightly increased our position in Safran after its earnings release. We initiated a position in EssilorLuxottica by selling our Carrefour shares.

Characteristics

General data

Inception date
28/03/2023
First Nav Date
28/03/2023
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
100000 euros
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs0.97% of the value of your investment per year. This percentage is based on actual costs over the last year.€91.77
Transaction costs0.24% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell.€22.86
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

15.00% annual outperformance of the reference asset 100% MSCI EMU NR Close. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€10.07

Codification

ISIN code
LU2570611249
Bloomberg code
CPEUSTI LX
Reuters code

Investment Objective

The investment objective is to outperform European equity markets over a long-term period (minimum of five years) by investing in equities involved in strategic sectors that contribute to Europe’s autonomy and resilience, while integrating Environmental, Social and Governance (ESG) criteria in the investment process.
 

Documents

LanguageDocumentsTypeClosing Date
SV
PDF
01/09/2026
EN
PDF
31/07/2025
PDF
01/10/2026
PDF
31/01/2026
SV
PDF
31/10/2026
EN
PDF
26/10/2016